Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

The Food and Drug Administration has required Pfizer and Moderna to expand the warning labels on their mRNA COVID-19 vaccines ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The U.S. CDC recommends RSV vaccines for high-risk adults aged 50-59, endorsing the views of the former vaccine advisory ...

The Trump administration is continuing to make its imprint on U.S. vaccine policy in recent days. The moves could change what ...

Health Secretary Robert F. Kennedy Jr.'s newly reconstituted vaccine advisory panel is facing criticism from medical experts.

The Food and Drug Administration has updated its warning labels for the Pfizer and Moderna COVID-19 vaccines, expanding ...